State of the Art: acute treatment of pulmonary embolism

26 August 2017 (13:30 - 13:48)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Professor Nils Kucher

University Hospital Zurich, Zurich (Switzerland)

4 More presentations in this session

Presentation thumbnail

Determinants of the long-term haemodynamic course and late sequelae after acute intermediate-risk pulmonary embolism: results from a randomized thrombolysis trial

Doctor S. Barco (Zurich, CH)

Abstract Slides Video

Presentation thumbnail

Validation of the VTE-BLEED score for predicting 30-day major bleeding in a real-world cohort of patients with pulmonary embolism

Mr K. Kresoja (Mainz, DE)

Abstract Slides Video

Presentation thumbnail

Effectiveness and safety of continued oral anticoagulation treatment beyond 1 year after venous thromboembolism in patients at intermediate risk: a nationwide propensity score weighted-cohort study

Associate Professor S. Johnsen (Aalborg, DK)

Abstract Slides Video

Presentation thumbnail

Selecting the optimal duration and regimen of anticoagulation after pulmonary embolism

Professor S. Konstantinides (Mainz, DE)

Access the full session

Session thumbnail

After pulmonary embolism: optimising treatment and follow up

The Event

ESC Congress 2017

26 August 2017 13:30 CET

You may be interested in

Congress Presentation

Q&A

31 August 2025

Congress Presentation

Use of advanced therapies for pulmonary embolism among pregnant or postpartum women.

24 March 2023

Congress Presentation

Effectiveness and safety of half-dose thrombolysis in intermediate-high risk pulmonary embolism: a single centre experience

9 March 2024

Congress Presentation

Redefining treatment paradigms for patients with acute pulmonary embolism and patent foramen ovale

1 September 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources